Index of reports
> Life Threatening Events (66)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 66 Next >>
Possible Depakene side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Multi-Organ Failure, Diarrhoea, Acute Respiratory Distress Syndrome, Hepatorenal Failure, Drug Rash With Eosinophilia and Systemic Symptoms, Convulsion, Disease Progression
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2006-11-11
End date: 2009-09-07
Phenytoin Sodium CAP
Indication: Status Epilepticus
Start date: 2009-06-25
End date: 2009-09-07
Tegretol
Administration route: Oral
Indication: Status Epilepticus
Start date: 2009-06-25
End date: 2009-09-07
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Start date: 2010-06-11
End date: 2010-10-05
Temodal
Administration route: Oral
Start date: 2008-02-21
End date: 2008-02-25
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Start date: 2009-09-28
End date: 2010-05-04
Temodal
Administration route: Oral
Start date: 2007-11-29
End date: 2007-12-03
Temodal
Administration route: Oral
Start date: 2008-04-17
End date: 2008-04-21
Temodal
Administration route: Oral
Start date: 2008-10-02
End date: 2008-10-06
Temodal
Administration route: Oral
Start date: 2008-10-30
End date: 2008-11-03
Temodal
Administration route: Oral
Start date: 2010-02-08
End date: 2010-02-12
Temodal
Administration route: Oral
Start date: 2010-03-08
End date: 2010-03-12
Temodal
Administration route: Oral
Start date: 2010-06-11
End date: 2010-06-15
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Start date: 2007-01-25
End date: 2009-05-18
Temodal
Administration route: Oral
Start date: 2007-03-22
End date: 2007-03-26
Temodal
Administration route: Oral
Start date: 2007-06-14
End date: 2007-06-18
Temodal
Administration route: Oral
Start date: 2007-08-09
End date: 2007-08-13
Temodal
Administration route: Oral
Start date: 2007-10-04
End date: 2007-10-08
Temodal
Administration route: Oral
Start date: 2009-12-14
End date: 2009-12-18
Temodal
Administration route: Oral
Start date: 2008-05-15
End date: 2008-05-19
Temodal
Administration route: Oral
Start date: 2009-10-26
End date: 2009-10-30
Temodal
Dosage: 75 mg/m2, qd
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-11-28
End date: 2006-12-26
Temodal
Administration route: Oral
Start date: 2007-02-22
End date: 2007-02-26
Temodal
Administration route: Oral
Start date: 2007-11-01
End date: 2007-11-05
Temodal
Administration route: Oral
Start date: 2008-03-20
End date: 2008-03-24
Temodal
Administration route: Oral
Start date: 2008-07-10
End date: 2008-07-14
Temodal
Administration route: Oral
Start date: 2009-01-22
End date: 2009-01-26
Temodal
Administration route: Oral
Start date: 2009-04-16
End date: 2009-04-20
Temodal
Administration route: Oral
Start date: 2010-01-11
End date: 2010-01-15
Temodal
Administration route: Oral
Start date: 2010-07-09
End date: 2010-07-13
Temodal
Administration route: Oral
Start date: 2010-09-03
End date: 2010-09-07
Temodal
Administration route: Oral
Start date: 2007-01-25
End date: 2007-01-29
Temodal
Administration route: Oral
Start date: 2007-09-06
End date: 2007-09-10
Temodal
Administration route: Oral
Start date: 2007-12-27
End date: 2007-12-31
Temodal
Administration route: Oral
Start date: 2008-01-24
End date: 2008-01-28
Temodal
Administration route: Oral
Start date: 2008-08-07
End date: 2008-08-11
Temodal
Administration route: Oral
Start date: 2009-03-19
End date: 2009-03-23
Temodal
Administration route: Oral
Start date: 2010-05-03
End date: 2010-05-04
Temodal
Administration route: Oral
Start date: 2007-04-19
End date: 2007-04-23
Temodal
Administration route: Oral
Start date: 2007-05-17
End date: 2007-05-21
Temodal
Administration route: Oral
Start date: 2007-07-12
End date: 2007-07-16
Temodal
Administration route: Oral
Start date: 2008-09-04
End date: 2008-09-08
Temodal
Administration route: Oral
Start date: 2008-11-28
End date: 2008-12-02
Temodal
Administration route: Oral
Start date: 2008-12-25
End date: 2008-12-29
Temodal
Administration route: Oral
Start date: 2009-02-19
End date: 2009-02-23
Temodal
Administration route: Oral
Start date: 2009-05-14
End date: 2009-05-18
Temodal
Administration route: Oral
Start date: 2009-09-28
End date: 2009-10-02
Temodal
Administration route: Oral
Start date: 2010-04-05
End date: 2010-04-09
Temodal
Administration route: Oral
Start date: 2008-06-12
End date: 2008-06-16
Temodal
Administration route: Oral
Start date: 2010-08-06
End date: 2010-08-10
Temodal
Administration route: Oral
Start date: 2010-10-01
End date: 2010-10-05
Other drugs received by patient: Depakene; Phenobarbital TAB; Betamethasone Sodium Phosphate; Kytril; Zonisamide; Diprivan; Isozol; Topiramate; Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Streptococcus Faec
Possible Depakene side effects in male
Reported by a physician from Italy on 2012-08-13
Patient: male
Reactions: Hyperthermia, Suicide Attempt
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Major Depression
Start date: 2011-06-01
End date: 2011-10-01
Escitalopram
Administration route: Oral
Indication: Major Depression
Start date: 2011-06-01
End date: 2011-10-01
Seroquel
Administration route: Oral
Indication: Major Depression
Start date: 2011-06-01
End date: 2011-10-01
Possible Depakene side effects in male
Reported by a physician from Japan on 2012-08-07
Patient: male
Reactions: Pyrexia, Eczema, Lymphocyte Stimulation Test Positive, Oral Mucosa Erosion, Stevens-Johnson Syndrome, LIP Erosion
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 500mg per day
Administration route: Oral
Indication: Mood Swings
Start date: 2012-01-23
End date: 2012-06-22
Lamictal
Dosage: 12.5mg per day
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-05-28
End date: 2012-06-01
Lamictal
Dosage: 25mg per day
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-22
Topiramate
Dosage: 350mg per day
Administration route: Oral
Indication: Post-Traumatic Stress Disorder
Start date: 2012-01-23
End date: 2012-06-22
Possible Depakene side effects in 67 year old female
Reported by a physician from Japan on 2012-07-31
Patient: 67 year old female, weighing 42.0 kg (92.4 pounds)
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Dosage: 0.4 mg, as needed
Indication: Antipyresis
Start date: 2012-01-01
End date: 2012-05-07
Acetaminophen
Indication: Analgesic Therapy
Albumin Tannate
Dosage: 1 g, as needed
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-27
End date: 2012-05-07
Alfarol
Dosage: 0.5 ug (1ml) a day
Indication: Osteoporosis
Start date: 2012-04-19
End date: 2012-05-07
Ambisome
Dosage: 100 mg a day
Indication: Infection
Start date: 2012-04-25
End date: 2012-05-04
Cefazolin Sodium
Dosage: 1 g, 3x/day
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-19
End date: 2012-05-07
Clindamycin HCL
Indication: Muscle Abscess
Clindamycin HCL
Dosage: 1200 mg, 2x/day
Indication: Meningitis
Start date: 2012-04-11
End date: 2012-05-06
Depakene
Dosage: 400 mg (8ml) daily
Indication: Convulsion
Start date: 2012-04-13
End date: 2012-05-07
Lansoprazole
Dosage: 30 mg a day
Indication: Gastric Ulcer
Start date: 2012-03-21
End date: 2012-05-07
Lendormin
Dosage: 0.25 mg, as needed
Indication: Insomnia
Start date: 2012-04-21
Meropenem
Dosage: 2 g, daily
Start date: 2012-04-27
End date: 2012-05-06
Meropenem
Dosage: 1 g, daily
Indication: Muscle Abscess
Start date: 2012-04-11
End date: 2012-04-20
Meropenem
Dosage: 2mg, daily
Indication: Meningitis
Start date: 2012-01-17
End date: 2012-02-16
Vancomycin
Dosage: 0.5g/2days
Indication: Muscle Abscess
Start date: 2012-03-07
End date: 2012-04-09
Vancomycin
Dosage: 1 g/4days
Indication: Meningitis
Start date: 2012-02-07
End date: 2012-02-15
Vancomycin
Dosage: 0.5g/4days
Start date: 2012-04-27
End date: 2012-05-06
Other drugs received by patient: Ceftriaxone; Isoniazid; Ethambutol; Rifampicin; Prodif; Prednisolone; Ampicillin; Pyrazinamide
Possible Depakene side effects in female
Reported by a physician from China on 2012-07-30
Patient: female
Reactions: Hepatic Function Abnormal
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in 67 year old female
Reported by a physician from Japan on 2012-07-26
Patient: 67 year old female, weighing 42.0 kg (92.4 pounds)
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Indication: Analgesic Therapy
Acetaminophen
Dosage: 0.4 mg, as needed
Indication: Antipyresis
Start date: 2012-01-01
End date: 2012-05-07
Albumin Tannate
Dosage: 1 g, as needed
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-27
End date: 2012-05-07
Alfarol
Dosage: 0.5 ug (1ml) a day
Indication: Osteoporosis
Start date: 2012-04-19
End date: 2012-05-07
Ambisome
Dosage: 100 mg a day
Indication: Infection
Start date: 2012-04-25
End date: 2012-05-04
Cefazolin Sodium
Dosage: 1 g, 3x/day
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-19
End date: 2012-05-07
Clindamycin HCL
Dosage: 1200 g, 2x/day
Indication: Meningitis
Start date: 2012-04-11
End date: 2012-05-06
Clindamycin HCL
Indication: Muscle Abscess
Depakene
Dosage: 400 mg (8ml) daily
Indication: Convulsion
Start date: 2012-04-13
End date: 2012-05-07
Lansoprazole
Dosage: 30 mg a day
Indication: Gastric Ulcer
Start date: 2012-03-21
End date: 2012-05-07
Lendormin
Dosage: 0.25 mg, as needed
Indication: Insomnia
Start date: 2012-04-21
Meropenem
Dosage: 2 g, daily
Start date: 2012-04-27
End date: 2012-05-06
Meropenem
Dosage: 1 g, daily
Indication: Muscle Abscess
Start date: 2012-04-11
End date: 2012-04-20
Meropenem
Dosage: 2mg, daily
Indication: Meningitis
Start date: 2012-01-17
End date: 2012-02-16
Vancomycin
Dosage: 0.5g/2days
Indication: Muscle Abscess
Start date: 2012-03-07
End date: 2012-04-09
Vancomycin
Dosage: 1 g/4days
Indication: Meningitis
Start date: 2012-02-07
End date: 2012-02-15
Vancomycin
Dosage: 0.5g/4days
Start date: 2012-04-27
End date: 2012-05-06
Other drugs received by patient: Prednisolone; Isoniazid; Rifampicin; Ethambutol; Prodif; Ceftriaxone; Ampicillin; Pyrazinamide
Possible Depakene side effects in 67 year old female
Reported by a physician from Japan on 2012-07-20
Patient: 67 year old female, weighing 42.0 kg (92.4 pounds)
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Dosage: 0.4 mg, as needed
Indication: Antipyresis
Start date: 2012-01-01
End date: 2012-05-07
Acetaminophen
Indication: Analgesic Therapy
Albumin Tannate
Dosage: 1 g, as needed
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-27
End date: 2012-05-07
Alfarol
Dosage: 0.5 ug (1ml) a day
Indication: Osteoporosis
Start date: 2012-04-19
End date: 2012-05-07
Ambisome
Dosage: 100 mg a day
Indication: Infection
Start date: 2012-04-25
End date: 2012-05-04
Cefazolin Sodium
Dosage: 1 g, 3x/day
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-19
End date: 2012-05-07
Clindamycin HCL
Indication: Muscle Abscess
Clindamycin HCL
Dosage: 1200 g, 2x/day
Indication: Meningitis
Start date: 2012-04-11
End date: 2012-05-06
Depakene
Dosage: 400 mg (8ml) daily
Indication: Convulsion
Start date: 2012-04-13
End date: 2012-05-07
Lansoprazole
Dosage: 30 mg a day
Indication: Gastric Ulcer
Start date: 2012-03-21
End date: 2012-05-07
Lendormin
Dosage: 0.25 mg, as needed
Indication: Insomnia
Start date: 2012-04-21
Meropenem
Dosage: 2 g, daily
Start date: 2012-04-27
End date: 2012-05-06
Meropenem
Dosage: 0.5 g, daily
Indication: Meningitis
Start date: 2012-01-17
End date: 2012-02-16
Meropenem
Dosage: 1 g, daily
Indication: Muscle Abscess
Start date: 2012-04-11
End date: 2012-04-20
Vancomycin
Dosage: 0.25 mg, 2x/day, every other day
Indication: Muscle Abscess
Start date: 2012-03-07
End date: 2012-04-09
Vancomycin
Dosage: 0.25 g, 2x/week
Start date: 2012-04-27
End date: 2012-05-06
Vancomycin Hychloride
Dosage: 0.25 g, 2x/week
Indication: Meningitis
Start date: 2012-02-07
End date: 2012-02-15
Other drugs received by patient: Ampicillin; Rifampicin; Pyrazinamide; Ethambutol; Prednisolone; Isoniazid; Prodif; Ceftriaxone
Possible Depakene side effects in 61 year old male
Reported by a physician from Japan on 2012-07-18
Patient: 61 year old male
Reactions: Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depakene
Dosage: daily dose: 400 mg
Administration route: Oral
Indication: Partial Seizures With Secondary Generalisation
End date: 2012-04-19
Keppra
Administration route: Oral
Indication: Partial Seizures With Secondary Generalisation
Start date: 2012-03-19
End date: 2012-03-25
Keppra
Administration route: Oral
Start date: 2012-03-11
End date: 2012-03-18
Other drugs received by patient: Diapp; Lamictal; Phenobarbital TAB
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18
Patient: male
Reactions: Hypotension, Hypoglycaemia, Bradykinesia, Sopor, Bradyphrenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril
Possible Depakene side effects in 67 year old female
Reported by a physician from Japan on 2012-07-12
Patient: 67 year old female, weighing 42.0 kg (92.4 pounds)
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Indication: Analgesic Therapy
Acetaminophen
Dosage: 0.4 mg, as needed
Indication: Antipyresis
Start date: 2012-01-01
End date: 2012-05-07
Albumin Tannate
Dosage: 1 g, as needed
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-27
End date: 2012-05-07
Alfarol
Dosage: 0.5 ug (1ml) a day
Indication: Osteoporosis
Start date: 2012-04-19
End date: 2012-05-07
Ambisome
Dosage: 100 mg a day
Indication: Infection
Start date: 2012-04-25
End date: 2012-05-04
Cefazolin Sodium
Dosage: 1 g, 3x/day
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-19
End date: 2012-05-07
Clindamycin HCL
Dosage: 1200 g, 2x/day
Indication: Meningitis
Start date: 2012-04-11
End date: 2012-05-06
Clindamycin HCL
Indication: Muscle Abscess
Depakene
Dosage: 400 mg (8ml) daily
Indication: Convulsion
Start date: 2012-04-13
End date: 2012-05-07
Lansoprazole
Dosage: 30 mg a day
Indication: Gastric Ulcer
Start date: 2012-03-21
End date: 2012-05-07
Lendormin
Dosage: 0.25 mg, as needed
Indication: Insomnia
Start date: 2012-04-21
Meropenem
Dosage: 0.5 g, daily
Indication: Meningitis
Start date: 2012-01-17
End date: 2012-02-16
Meropenem
Dosage: 2 g, daily
Start date: 2012-04-27
End date: 2012-05-06
Meropenem
Dosage: 1 g, daily
Indication: Muscle Abscess
Start date: 2012-04-11
End date: 2012-04-20
Vancomycin Hydrochloride
Dosage: 0.25 mg, 2x/day, every other day
Indication: Muscle Abscess
Start date: 2012-03-07
End date: 2012-04-09
Vancomycin Hydrochloride
Dosage: 0.25 g, 2x/week
Indication: Meningitis
Start date: 2012-02-07
End date: 2012-02-15
Vancomycin Hydrochloride
Dosage: 0.25 g, 2x/week
Start date: 2012-04-27
End date: 2012-05-06
Other drugs received by patient: Rifampicin; Ethambutol; Pyrazinamide; Prodif; Prednisolone; Isoniazid; Ceftriaxone; Ampicillin
Possible Depakene side effects in male
Reported by a physician from France on 2012-07-10
Patient: male
Reactions: Pancreatitis Acute, Pneumonia, Systemic Inflammatory Response Syndrome, Circulatory Collapse, Respiratory Distress, Organ Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Aspirin
Administration route: Oral
Indication: Cerebrovascular Accident
Depakene
Administration route: Oral
Indication: Epilepsy
End date: 2012-02-28
Dipiperon
Administration route: Oral
Diprivan
Indication: Anaesthesia
Start date: 2012-02-27
End date: 2012-02-27
Lioresal
Indication: Cerebrovascular Accident
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-09
Patient: male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra
Dosage: 100 iu/milliltre, 3 milliliters once
Indication: Type 1 Diabetes Mellitus
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Indication: Suicide Attempt
Depakene
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Indication: Suicide Attempt
Duloxetime Hydrochloride
Dosage: once
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Dosage: once
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: once
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Indication: Suicide Attempt
Optiset
Dosage: 3 times a day, once
Indication: Device Therapy
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in 40 year old male
Reported by a physician from Italy on 2012-07-06
Patient: 40 year old male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Depakene
Dosage: dose:60 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Humalog
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Indication: Diabetic Neuropathy
Optiset
Indication: Device Therapy
Optiset
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in 12 year old female
Reported by a consumer/non-health professional from Brazil on 2012-07-05
Patient: 12 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Incorrect Dose Administered
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depakene
Dosage: 1 tablet per night
Administration route: Oral
Indication: Convulsion
Depakene
Dosage: 4 tablets at once
Start date: 2012-07-02
Other drugs received by patient: Unspecified Drug
Possible Depakene side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03
Patient: 67 year old female
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Indication: Analgesic Therapy
Start date: 2012-01-01
End date: 2012-05-07
Acetaminophen
Indication: Antipyresis
Start date: 2012-01-01
End date: 2012-05-07
Albumin Tannate
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-27
End date: 2012-05-07
Alfarol
Indication: Osteoporosis
Start date: 2012-04-19
End date: 2012-05-07
Ambisome
Indication: Fungal Infection
Start date: 2012-04-25
End date: 2012-05-04
Ambisome
Indication: Device Related Infection
Start date: 2012-04-25
End date: 2012-05-04
Buprenorphine HCL
Cefazolin Sodium
Indication: Prophylaxis Against Diarrhoea
Start date: 2012-04-19
End date: 2012-05-07
Clindamycin
Indication: Meningitis
Start date: 2012-04-11
End date: 2012-05-06
Clindamycin
Indication: Psoas Abscess
Start date: 2012-04-11
End date: 2012-05-06
Depakene
Indication: Convulsion
Start date: 2012-04-13
End date: 2012-05-07
Lansoprazole
Indication: Gastric Ulcer
Start date: 2012-03-21
End date: 2012-05-07
Lendormin
Indication: Insomnia
Start date: 2012-04-21
Meropenem
Start date: 2012-04-11
End date: 2012-04-20
Meropenem
Start date: 2012-04-11
End date: 2012-04-20
Meropenem
Start date: 2012-04-27
End date: 2012-05-06
Meropenem
Start date: 2012-04-27
End date: 2012-05-06
Meropenem
Indication: Meningitis
Start date: 2012-01-17
End date: 2012-02-16
Meropenem
Indication: Psoas Abscess
Start date: 2012-01-17
End date: 2012-02-16
Prodif
Start date: 2012-04-11
End date: 2012-04-23
Vancomycin Hydrochloride
Indication: Meningitis
Start date: 2012-02-07
End date: 2012-02-15
Vancomycin Hydrochloride
Start date: 2012-03-07
End date: 2012-04-09
Vancomycin Hydrochloride
Start date: 2012-04-27
End date: 2012-05-06
Vancomycin Hydrochloride
Start date: 2012-03-07
End date: 2012-04-09
Vancomycin Hydrochloride
Indication: Psoas Abscess
Start date: 2012-02-07
End date: 2012-02-15
Vancomycin Hydrochloride
Start date: 2012-04-27
End date: 2012-05-06
Other drugs received by patient: Prednisolone Sodium Succinate INJ; Concentrated Human RED Blood Cells; Fresh Frozen Human Plazma
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-06-26
Patient: female
Reactions: Drug Eruption, Lymphadenopathy, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Malaise, Blood Fibrinogen Decreased, Fibrin D Dimer Increased, C-Reactive Protein Increased, Decreased Appetite, Blood Alkaline Phosphatase Increased, Viral Infection, Kidney Enlargement, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Lamictal
Dosage: 25mg twice per day
Administration route: Oral
Indication: Bipolar II Disorder
Start date: 2012-05-07
End date: 2012-05-23
Other drugs received by patient: Dogmatyl; Risperdal; Desyrel; Clonazepam; Pursennid; Magmitt
Possible Depakene side effects in female
Reported by a pharmacist from Japan on 2012-06-20
Patient: female
Reactions: Drug Eruption, Hepatic Function Abnormal, Lymphadenopathy, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Fibrin D Dimer Increased, Blood Alkaline Phosphatase Increased, Viral Infection, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Lamictal
Dosage: 25mg twice per day
Administration route: Oral
Indication: Bipolar II Disorder
Start date: 2012-05-07
End date: 2012-05-23
Other drugs received by patient: Clonazepam; Dogmatyl; Pursennid; Risperdal; Magmitt; Desyrel
Possible Depakene side effects in 61 year old male
Reported by a physician from Japan on 2012-06-18
Patient: 61 year old male
Reactions: Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depakene
Dosage: daily dose: 400 mg
Administration route: Oral
Indication: Partial Seizures With Secondary Generalisation
Start date: 2012-03-09
End date: 2012-04-19
Keppra
Administration route: Oral
Indication: Partial Seizures With Secondary Generalisation
Start date: 2012-03-19
End date: 2012-03-25
Keppra
Administration route: Oral
Start date: 2012-03-11
End date: 2012-03-18
Other drugs received by patient: Phenobarbital TAB; Lamictal; Diapp
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-18
Patient: male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra
Dosage: once
Indication: Type 1 Diabetes Mellitus
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Indication: Suicide Attempt
Depakene
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Dosage: once
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Indication: Suicide Attempt
Humalog
Dosage: once
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: once
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Indication: Suicide Attempt
Optiset
Dosage: 3 in 1 day, once
Indication: Device Therapy
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-15
Patient: male
Reactions: Hypokinesia, Intentional Overdose, Hypotension, Hypoglycaemia, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra
Dosage: once
Indication: Type 1 Diabetes Mellitus
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Indication: Suicide Attempt
Depakene
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Dosage: once
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Indication: Suicide Attempt
Humalog
Dosage: once
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: once
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Indication: Suicide Attempt
Optiset
Dosage: 3 in 1 day, once
Indication: Device Therapy
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril
Possible Depakene side effects in 40 year old male
Reported by a physician from Italy on 2012-06-15
Patient: 40 year old male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Dosage: dose:60 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Indication: Diabetic Neuropathy
Optiset
Indication: Device Therapy
Optiset
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in 40 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13
Patient: 40 year old male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Dosage: dose:60 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Duloxetine Hydrochloride
Administration route: Oral
Humalog
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Indication: Diabetic Neuropathy
Lyrica
Administration route: Oral
Optiset
Indication: Device Therapy
Optiset
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril
Possible Depakene side effects in female
Reported by a physician from Japan on 2012-06-12
Patient: female
Reactions: Drug Eruption, Hepatic Function Abnormal, Lymphadenopathy, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Blood Fibrinogen Decreased, Fibrin D Dimer Increased, C-Reactive Protein Increased, Blood Alkaline Phosphatase Increased, Viral Infection, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 600mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Bipolar II Disorder
Start date: 2012-05-07
End date: 2012-05-23
Other drugs received by patient: Dogmatyl; Desyrel; Magmitt; Clonazepam; Risperdal; Pursennid
Possible Depakene side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-06-05
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Escitalopram
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Fluvastatin
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Pantoprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Tramadol HCL
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Tramadol Hydrochloride and Acetaminophen
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Possible Depakene side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-06-01
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Escitalopram
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Fluvastatin
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Pantoprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Tramadol HCL
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Ultracet
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Possible Depakene side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-31
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatinaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 400 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Escitalopram
Dosage: 5 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Fluvastatin
Dosage: 80 mg
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Pantoprazole
Dosage: 40 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Tramadol HCL
Dosage: 150 mg
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Ultracet
Dosage: 3 df
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Possible Depakene side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-05-29
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Escitalopram
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Fluvastatin
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Pantoprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Tramadol HCL
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Ultracet
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Possible Depakene side effects in female
Reported by a physician from France on 2012-05-24
Patient: female
Reactions: Pruritus, Lymphadenopathy, Drug Interaction, Pyrexia, Erythema, Face Oedema, Conjunctival Hyperaemia, Dermatitis Bullous, Skin Disorder, Toxic Epidermal Necrolysis, Vulvar Erosion, Nikolsky's Sign, Mucosal Erosion, Respiratory Tract Congestion, Lacrimation Increased, Rash Maculo-Papular, Toxic Skin Eruption, Keratitis, Inflammation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2008-12-21
End date: 2009-04-18
Lamictal
Administration route: Oral
Indication: Epilepsy
Start date: 2009-03-31
End date: 2009-04-15
Other drugs received by patient: Norlevo; Clobazam
Possible Depakene side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-18
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 400 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Escitalopram
Dosage: 5 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Fluvastatin
Dosage: 80 mg
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Pantoprazole
Dosage: 40 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Tramadol Hydrochloride
Dosage: 150 mg
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Ultracet
Dosage: 3 df
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Possible Depakene side effects in 61 year old male
Reported by a physician from Japan on 2012-05-17
Patient: 61 year old male
Reactions: Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Depakene
Dosage: daily dose: 8ml
Administration route: Oral
Indication: Partial Seizures With Secondary Generalisation
Start date: 2012-03-09
End date: 2012-04-19
Keppra
Administration route: Oral
Start date: 2012-03-11
End date: 2012-03-18
Keppra
Administration route: Oral
Indication: Partial Seizures With Secondary Generalisation
Start date: 2012-03-19
End date: 2012-03-25
Other drugs received by patient: Lamictal; Phenobarbital TAB; Diapp
Page 1 Next >>
|